Tarsus Pharmaceuticals (TARS) Capital Expenditures (2019 - 2026)
Tarsus Pharmaceuticals' Capital Expenditures was $4.07 million in Q2 2026, up 306.5% from $1 million a year earlier but down 30.1% from the prior quarter.
Tarsus Pharmaceuticals (TARS) Capital Expenditures (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tarsus Pharmaceuticals' Capital Expenditures was $18.16 million through Jun 30, 2026, up 833.4% year-over-year; for FY2025, it was $9.86 million, up 529.2% from FY2024.
- Capital Expenditures has now increased for three consecutive years, with a five-year compound annual growth rate of 84.9% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $1.57 million in FY2024 (+4.3%), $1.5 million in FY2023 (+196.8%), $506,000 in FY2022 (-13.7%) and $586,000 in FY2021 (+28.5%).
- Quarterly Capital Expenditures has moved between $72,000 (Q4 2024) and $6.36 million (Q4 2025) over five years.
- Compared with a year earlier, Capital Expenditures was higher in four of the last six quarters, with growth averaging 330.1%.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2026 (growth of 886.1%); the worst was Q4 2022 (a decline of 53.6%).
- Per Business Quant data, TARS's Capital Expenditures in the three quarters before Q2 2026 was $5.82 million (Q1 2026), $6.36 million (Q4 2025) and $1.91 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Tarsus Pharmaceuticals | 3.32 Bn | 2.26 Bn | 161.80 Mn | 4.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.07 Mn |
| Mar 31, 2026 | 5.82 Mn |
| Dec 31, 2025 | 6.36 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 174,000.00 |
| Sep 30, 2023 | 375,000.00 |
| Jun 30, 2023 | 787,000.00 |
| Mar 31, 2023 | 340,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 96,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Mar 31, 2022 | 161,000.00 |
| Dec 31, 2021 | 274,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Jun 30, 2021 | 16,000.00 |
Tarsus Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TARS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();